BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 19678720)

  • 1. AMCP Guide to Pharmaceutical Payment Methods, 2009 Update (Version 2.0).
    Academy of Managed Care Pharmacy
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl A):S3-57, quiz S58-61. PubMed ID: 19678720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the price benchmark to replace average wholesale price (AWP)?
    Curtiss FR; Lettrich P; Fairman KA
    J Manag Care Pharm; 2010 Sep; 16(7):492-501. PubMed ID: 20726678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One pill, many prices: variation in prescription drug prices in selected government programs.
    Gencarelli DM
    Issue Brief George Wash Univ Natl Health Policy Forum; 2005 Aug; (807):1-20. PubMed ID: 16167399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.
    Balkhi B; Seoane-Vazquez E; Rodriguez-Monguio R
    Int J Technol Assess Health Care; 2016 Jan; 32(6):385-392. PubMed ID: 28065194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
    Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
    PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative strategies for Medicare payment of outpatient prescription drugs--Part B and beyond.
    Danzon PM; Wilensky GR; Means KE
    Am J Manag Care; 2005 Mar; 11(3):173-80. PubMed ID: 15786856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of US Drug Costs Relevant to Medicare, Medicaid, and Commercial Insurers Post-Affordable Care Act Enactment, 2010-2016.
    McRae J; Vogenberg FR; Beaty SW; Mearns E; Varga S; Pizzi L
    Pharmacoeconomics; 2017 Feb; 35(2):215-223. PubMed ID: 27798809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical pricing benchmarks: governmental versus private sector.
    Turkistani F; Sawad AB
    J Comp Eff Res; 2020 Oct; 9(15):1091-1100. PubMed ID: 33052057
    [No Abstract]   [Full Text] [Related]  

  • 13. AMCP Partnership Forum: What's Next for Specialty Medication Benefit Design and Reimbursement.
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1206-1213. PubMed ID: 32780612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals: Medicare Modernization Act--2005. End of Year Issue Brief.
    Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-21. PubMed ID: 16710928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician payment outlook for 2012: déjà vu.
    Manchikanti L; Singh V; Caraway DL; Benyamin RM; Falco FJ; Hirsch JA
    Pain Physician; 2012; 15(1):E27-52. PubMed ID: 22270747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G; Weiss RC
    Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism?
    Gencarelli DM
    NHPF Issue Brief; 2002 Jun; (775):1-19. PubMed ID: 12083159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saga of payment systems of ambulatory surgery centers for interventional techniques: an update.
    Manchikanti L; Singh V; Hirsch JA
    Pain Physician; 2012; 15(2):109-30. PubMed ID: 22430649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.